Abstract
Once the genetic defect of cystic fibrosis (CF), the most common autosomal recessive disease, was discovered, there was hope for quick positive results with gene-therapy. These did not came true, however. Recent CF mice studies by Freedman et al. demonstrated a disease reversal by high doses of docosahexaenoic acid (DHA). Although it is known for long that the same essential fatty acid imbalance with low levels of DHA is present in CF patients and that DHA has antiinflammatory actions, caution is urged to prevent false expectations when we extrapolate mice model results. This review explores the present scientific data on DHA supplementation in CF.
Keywords: Polyunsaturated Fatty Acids, CF transmembrane conductance regulator (CFTR), Phospholipid, Eicosapentaenoic acid, inflammation
Current Pediatric Reviews
Title: Not Just any Fat for Cystic Fibrosis? Docosahexaenoic Acid in Cystic Fibrosis
Volume: 2 Issue: 2
Author(s): Stephanie v. Biervliet, Jean-Pierre v. Biervliet, Eddy Robberecht and Armand Christophe
Affiliation:
Keywords: Polyunsaturated Fatty Acids, CF transmembrane conductance regulator (CFTR), Phospholipid, Eicosapentaenoic acid, inflammation
Abstract: Once the genetic defect of cystic fibrosis (CF), the most common autosomal recessive disease, was discovered, there was hope for quick positive results with gene-therapy. These did not came true, however. Recent CF mice studies by Freedman et al. demonstrated a disease reversal by high doses of docosahexaenoic acid (DHA). Although it is known for long that the same essential fatty acid imbalance with low levels of DHA is present in CF patients and that DHA has antiinflammatory actions, caution is urged to prevent false expectations when we extrapolate mice model results. This review explores the present scientific data on DHA supplementation in CF.
Export Options
About this article
Cite this article as:
Biervliet v. Stephanie, Biervliet v. Jean-Pierre, Robberecht Eddy and Christophe Armand, Not Just any Fat for Cystic Fibrosis? Docosahexaenoic Acid in Cystic Fibrosis, Current Pediatric Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339606776894658
DOI https://dx.doi.org/10.2174/157339606776894658 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
(Phospho)lipid-based Nanosystems for Skin Administration
Current Pharmaceutical Design Fractional Flow Reserve: Physiological Basis, Advantages and Limitations, and Potential Gender Differences
Current Cardiology Reviews Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Nanocarriers Loaded with Oxygen to Improve the Protection of the Heart to be Transplanted
Current Pharmaceutical Design Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond
Current Medicinal Chemistry The Neurovascular Protection Afforded by Delayed Local Hypothermia after Transient Middle Cerebral Artery Occlusion
Current Neurovascular Research Maternal Vitamin D Status and Development of Asthma and Allergy in Early Childhood
Mini-Reviews in Medicinal Chemistry Selected Herbals for Sports Injuries
The Natural Products Journal Research Strategies for Pain in Lumbar Radiculopathy Focusing on Acid-Sensing Ion Channels and Their Toxins
Current Topics in Medicinal Chemistry Biology of Transforming Growth Factor-β Signaling
Current Pharmaceutical Biotechnology Prediction and Prevention of Abnormal Antenatal Lung Growth
Current Respiratory Medicine Reviews Disorders of Respiration and Sleep-Disordered Breathing in Patients with Chronic Renal Failure
Current Respiratory Medicine Reviews Is there Evidence to Support the Use of Direct Factor Xa Inhibitors in Coronary Artery Disease?
Reviews on Recent Clinical Trials Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy Neuromuscular Blockade in the Optimal Management of Mechanical Ventilation of Patients with Respiratory Distress
Current Respiratory Medicine Reviews A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Cardiovascular-Active Venom Toxins: An Overview
Current Medicinal Chemistry Gadolinium-Enhanced Magnetic Resonance Imaging, Renal Failure and Nephrogenic Systemic Fibrosis /Nephrogenic Fibrosing Dermopathy
Current Medicinal Chemistry